Shandong Xinhua Pharmaceutical Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shandong Xinhua Pharmaceutical Co., Ltd. - overview
Established
1943
Location
-, -, China
Primary Industry
Pharmaceuticals
About
Founded in 1943 and based in China, Shandong Xinhua Pharmaceutical Co. , Ltd. engages in the development, production, and sales of pharmaceutical and synthetic chemical products. The organization has three pillar industries of chemical raw materials, pharmaceutical preparations and pharmaceutical intermediates, 5 industrial parks, and 13 subsidiaries.
In January 2022, Xinhua bio Pharmaceutical (Guangzhou) Co Ltd. raised CNY 100 million in venture funding led by Jingwei Ventures including danlu. com and Sequoia Capital China. The Company provides products for antipyretic, analgesic, anti-inflammatory, sedative-hypnotic, adrenocortical hormones, antihypertensive, antibiotics, hypoglycemic, digestive system, antiparasitic.
The products include analgin, caffeine, amidopyrine, ibuprofen, theophylline, aspirin, magnesium, and more. It operates the business through the following segments: bulk pharmaceuticals, preparations, chemicals, and other products. The enterprise plans to use the January 2022 funding for its AI computing and biological platform expansion, self-research project promotion, and talent team expansion.
Current Investors
Sequoia, Danlu, Jingwei Ventures
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Biopharmaceuticals, Pharmaceuticals
Website
www.xhzy.com
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.